Furthermore, we supplemented AKT1 activator (SC79) and inhibitor (MK-2206 2HCl) to interfere with the neutrophil growth, respectively, and discussed the relevant regulatory mechanism of HXTLF on vasculitis treatment. The gene discussed is AKT1; the disease is vasculitis.